Ambroxol

Ambroxol is a mucolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It is a metabolite of bromhexine and is clinically proven to make mucus less viscous and easier to expel. Ambroxol is often used to help relieve productive cough and is included in various over-the-counter and prescription cough remedies.

Medical Uses

Ambroxol is primarily indicated for the management of bronchial diseases that involve abnormal mucus secretion and transport. It is effective in treating conditions such as chronic obstructive pulmonary disease (COPD), bronchitis, and asthma when accompanied by mucus hypersecretion. Ambroxol facilitates expectoration, eases productive cough, and helps in clearing the airways.

Mechanism of Action

The drug works by increasing the production of serous mucus in the respiratory tract, which makes the phlegm thinner and less sticky. This action enhances the activity of the cilia by reducing mucus viscosity, which in turn helps to clear mucus from the lungs. Ambroxol also has antioxidant properties, providing additional benefits in the inflammatory processes of the respiratory system.

Pharmacokinetics

After oral administration, Ambroxol is rapidly absorbed from the gastrointestinal tract. Its bioavailability is high due to its low first-pass metabolism. The drug is extensively metabolized in the liver, and its metabolites are excreted mainly through the urine. Ambroxol crosses the blood-brain barrier and the placental barrier and is found in breast milk.

Side Effects

Common side effects of Ambroxol include nausea, vomiting, diarrhea, and abdominal pain. Less frequently, it may cause allergic reactions such as rash, urticaria, and angioedema. Due to its ability to cross the placental barrier, caution is advised when prescribing Ambroxol to pregnant women, especially during the first trimester.

Dosage and Administration

Ambroxol is available in various forms, including tablets, syrup, and solution for inhalation. The dosage of Ambroxol depends on the age, weight, and condition of the patient. It is usually administered orally 2-3 times a day after meals. For inhalation forms, dosing frequency and duration depend on the severity of the condition being treated.

Precautions

Patients with a history of peptic ulcer disease or those allergic to Ambroxol or any of its components should avoid using this medication. Caution is also advised in patients with severe liver or kidney impairment, as dose adjustments may be necessary.

Interactions

Ambroxol may interact with certain medications, such as antibiotics, enhancing their concentration in the lung tissue. Patients should inform their healthcare provider about all the medications they are taking to avoid potential drug interactions.

‎